Failure of hexamethylmelamine as salvage therapy in ovarian epithelial adenocarcinoma resistant to combination chemotherapy
- 19 February 1984
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 17 (2), 189-195
- https://doi.org/10.1016/0090-8258(84)90076-3
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Advanced ovarian carcinoma: A prospective and randomized clinical trial of cyclophosphamide versus combination cytotoxic chemotherapy (Hexa-CAF)Cancer, 1981
- The role of hexamethylmelamine in advanced ovarian carcinoma treatmentGynecologic Oncology, 1981
- A randomized trial of Melphalan alone versus combination chemotherapy in advanced ovarian cancerGynecologic Oncology, 1980
- HEXAMETHYLMELAMINE IN OVARIAN-CANCER RESISTANT TO CYCLOPHOSPHAMIDE AND ADRIAMYCIN1979
- PHASE-II TRIAL OF HEXAMETHYLMELAMINE IN OVARIAN-CARCINOMA RESISTANT TO ALKYLATING-AGENTS1979
- Advanced Ovarian AdenocarcinomaNew England Journal of Medicine, 1978
- Hexamethylmelamine in alkylating agent-resistant ovarian carcinomaCancer, 1978
- Second trial drugs in ovarian cancerGynecologic Oncology, 1977
- Hexamethylmelamine.An evaluation of its role in the therapy of cancerCancer, 1976